<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00244504</url>
  </required_header>
  <id_info>
    <org_study_id>158/01</org_study_id>
    <nct_id>NCT00244504</nct_id>
  </id_info>
  <brief_title>Moxonidine in Patients Undergoing Vascular Surgery</brief_title>
  <official_title>The Effects of Small Doses of Moxonidine in Patients Undergoing Vascular Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigating the perioperative effect of moxonidine. In a randomized double-blind fashion,
      patients undergoing vascular surgery will receive moxonidine 0.2 mg or placebo from the day
      before surgery until day 4 after surgery. Holter-EKG for 48 h, starting just before surgery.
      Repeated 12-lead EKG, measurements of Troponin I and BNP, clinical visitations, follow-up
      interviews at 6 and 12 months
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Study was stopped after pre-definied interim analysis because of no effects
  </why_stopped>
  <start_date>November 2002</start_date>
  <completion_date type="Actual">March 2006</completion_date>
  <primary_completion_date type="Actual">March 2006</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>over-all mortality</measure>
    <time_frame>30 days and 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ischemia detected by Holter-ECG ST alterations or troponin T elevation</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">141</enrollment>
  <condition>Cardiac Disease</condition>
  <condition>Vascular Surgery</condition>
  <arm_group>
    <arm_group_label>I</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>moxonidine group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>II</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo group</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>moxonidine</intervention_name>
    <description>moxonidine 0.2 mg/d starting the morning of surgery until day 4 after surgery</description>
    <arm_group_label>I</arm_group_label>
    <arm_group_label>II</arm_group_label>
    <other_name>Physiotens</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  abdominal aortic or peripheral vascular surgery

        Exclusion Criteria:

          -  unstable angina,

          -  severe symptomatic heart failure (NYHA IV)

          -  systolic blood pressure at rest &lt; 100 mmHg

          -  bradycardia (&lt;50/min)

          -  higher grade AV heart block

          -  creatinine clearance &lt; 30 ml/min

          -  pregnancy

          -  no consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miodrag Filipovic, PD Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Basel, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University hospital</name>
      <address>
        <city>Basel</city>
        <state>CH</state>
        <zip>4000</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 25, 2005</study_first_submitted>
  <study_first_submitted_qc>October 25, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 26, 2005</study_first_posted>
  <last_update_submitted>November 9, 2009</last_update_submitted>
  <last_update_submitted_qc>November 9, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 10, 2009</last_update_posted>
  <responsible_party>
    <name_title>PD Dr. M. Filipovic, Co-Head of Cardiothoracic Anaesthesia</name_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Moxonidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

